Total planned funding: $203,371,054
Allocations
Countries/Regions
Eswatini | $203,371,054 |
Organizational Types
Private Contractor | $48,831,521 |
University | $43,601,572 |
NGO | $40,704,410 |
Unknown | $30,128,119 |
Own Agency | $23,926,106 |
Host Country Government Agency | $7,383,459 |
FBO | $6,188,454 |
Multi-lateral Agency | $1,410,000 |
Implementing Agency | $759,600 |
Other USG Agency | $437,813 |
Program Areas
Care | $61,797,628 |
Prevention | $41,610,590 |
Treatment | $40,845,458 |
Governance and Systems | $24,785,910 |
Testing | $18,868,069 |
Management and Operations | $15,463,399 |
Budget Codes
HTXS: Treatment: Adult Treatment | $33,536,810 |
HBHC: Care: Adult Care and Support | $29,585,428 |
HVCT: Testing: HIV Testing and Counseling | $18,868,069 |
HKID: Care: Orphans and Vulnerable Children | $18,462,195 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $16,813,195 |
HVMS: Management and Operations | $15,463,399 |
HVSI: Strategic Information | $10,956,095 |
OHSS: Health Systems Strengthening | $10,353,514 |
HVTB: Care: TB/HIV | $8,828,350 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $7,910,604 |
HVOP: Sexual Prevention: Other Sexual Prevention | $7,888,947 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $7,522,844 |
PDCS: Care: Pediatric Care and Support | $4,921,655 |
HTXD: Treatment: ARV Drugs | $4,462,964 |
HLAB: Laboratory Infrastructure | $3,476,301 |
PDTX: Treatment: Pediatric Treatment | $2,845,684 |
HMBL: Biomedical Prevention: Blood Safety | $1,475,000 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$36,609,037
Countries/Regions
Not Available:
$25,729,133
Countries/Regions
Pact, Inc.:
$24,302,240
Countries/Regions
USG Aggregated Agencies:
$16,189,354
Countries/Regions